INDEPENDENT VERDICT
SirenOpt Inc. is a verifiable 2022 Delaware manufacturing-technology company whose September 18, 2026 Form D reports a $32,411,720 offering, $19,428,895 sold to 17 investors and $12,982,825 remaining after a first sale on September 10. The issuer relies on Rule 506(b), is not a pooled investment fund, reports no commissions, finder fees or Item 16 related-person payments, and offers Equity together with securities issuable upon exercise of options, warrants or other rights. The most important disclosure is in Item 13: SirenOpt explicitly states that `$7,411,760` of the amount sold came from conversion of securities. That means the `$19.43M` headline should not be described as `$19.43M of fresh cash raised`; arithmetically, the non-conversion portion is approximately `$12.017M`, although the Form D does not disclose whether every dollar of that balance represents unrestricted cash received at closing.
THE CAPITAL STRUCTURE IS CATCHING UP WITH A COMPANY THAT HAS ALREADY MOVED BEYOND LAB SCIENCE
SirenOpt's operating story is much more mature than a first-time deep-tech raise. The company was founded in 2022 out of UC Berkeley's Chemical Engineering ecosystem by Jared O'Leary, Ali Mesbah and Joel Paulson, with Berkeley itself identifying O'Leary and Mesbah as inventors behind the technology and SirenOpt as a spinout focused on real-time manufacturing intelligence for thin films and micro- and nano-materials. Its PlasmaSens platform uses cold atmospheric plasma to interrogate materials non-destructively and combines the resulting signals with physics-informed machine learning and predictive analytics. The commercial objective is to replace or supplement slow, destructive, offline characterization with inline measurements during manufacturing—an especially valuable proposition in batteries, semiconductors, aerospace coatings, electronics and power-generation components where small material variations can destroy yield or create downstream safety problems. SirenOpt's current public materials say it has developed both roll-to-roll and piece-to-piece factory configurations and has performed evaluations or deployments with customers across the United States, Japan, Germany, the United Kingdom and Taiwan.
THE FINANCING HISTORY SHOWS A SHIFT FROM SEED VALIDATION TO INDUSTRIAL SCALE-UP
SirenOpt publicly closed a `$6.6M` seed round in July 2024 led by Voyager Ventures and TOMORROW, with participation from Union Labs, Berkeley SkyDeck Fund, Wireframe Ventures, Access Industries, Climate Club, Climate Capital and others; at that point the stated use of proceeds was to accelerate product development, launch commercial products and grow the team. By late 2025, the financing story had changed: SirenOpt announced strategic investment from Hitachi Ventures and InMotion Ventures, Jaguar Land Rover's venture arm, specifically to accelerate commercialization of PlasmaSens and factory-integrated systems. In parallel, the California Energy Commission awarded `$2.4M` in BRIDGE funding for battery-electrode manufacturing, while federal SBIR records show a separate `$274,770` NSF Phase I award for inline battery-electrode metrology. Those grant amounts, prior seed proceeds and strategic investments must remain separate from the latest SEC offering; they are useful evidence of technical and industrial validation but are not additional dollars inside the September 2026 Form D.
PLASMASENS IS TRYING TO SOLVE A FACTORY-FLOOR DATA PROBLEM THAT CONVENTIONAL LAB METROLOGY HANDLES POORLY
The platform's real differentiation is not simply that it uses plasma. Advanced coatings, electrodes and thin films often require multiple separate instruments to measure thickness, density, resistivity, composition and other properties, and many traditional methods are too slow or destructive to run continuously on a production line. SirenOpt instead generates a plasma-material interaction and captures a high-dimensional optical/electrical response that can be mapped back to material properties using physics-informed models. That architecture potentially creates a much faster feedback loop: a battery coating line, semiconductor process or turbine-blade coating operation can detect variation while material is being produced rather than discovering defects after a batch reaches offline quality control. The company's 2026 plan to deploy PlasmaSens Web inline at California's Electrochemistry Foundry is therefore strategically important because it moves the system from evaluation hardware toward continuous manufacturing integration. The risk also changes at this stage: success now depends less on whether plasma spectroscopy produces useful signals and more on uptime, calibration drift, integration with PLC/MES systems, repeatability across production lines, cybersecurity, customer qualification cycles and whether the system produces enough measurable yield improvement to justify industrial capex.
THE $7.41M CONVERSION DISCLOSURE MATTERS FOR VALUATION AND DILUTION
The conversion language deserves particular attention because it can materially distort comparisons between SEC filings and press-release financing totals. Converted securities can include earlier SAFEs, convertible notes or other instruments turning into equity as part of a priced financing; when that happens, Form D can count the converted securities within "amount sold" even though the issuer may have received the original cash months or years earlier. SirenOpt's filing does not identify what instruments produced the `$7.41176M` conversion amount, when the original money was received, what discount or valuation cap applied, or whether warrants or additional rights were issued alongside the conversion. Investors therefore need the capitalization table immediately before and after the transaction, the prior convertible instruments, new preferred-stock terms and fully diluted ownership schedule to understand how much new liquidity entered SirenOpt and how much of the round is capitalization cleanup. This is especially important because the offering also includes securities issuable upon exercise of options or warrants, meaning the stated `$32.41172M` ceiling may include value tied to future exercise rights rather than cash funded on the September closing date.
FINAL ASSESSMENT
SirenOpt's latest Form D marks a credible transition from university-originated deep technology toward factory-scale commercialization, but the capital headline needs to be read carefully. SEC EDGAR verifies a `$32.41172M` offering with `$19.428895M` sold to 17 investors and explicitly states that `$7.41176M` of that sold amount resulted from conversion of securities. Separately, the company has progressed from a `$6.6M` seed round into strategic backing from industrial investors, government-supported battery-manufacturing development and planned inline deployments. The strongest independent conclusion is therefore not simply that SirenOpt "raised $19.4M," but that a Berkeley-originated plasma metrology company is using a mixed new-money-and-conversion financing while moving PlasmaSens into production environments where uptime, process integration and measurable factory economics will determine whether the technology becomes standard industrial metrology rather than specialized sensing equipment. Investors should request the full conversion schedule, current cap table, preferred-stock terms, customer purchase orders, installed-system count, recurring software/service revenue, gross margin, calibration and reliability data and quantified customer yield improvements before using the Form D headline as a proxy for either new cash or commercial traction.
Form D is an exempt-offering notice. It is not SEC approval of SirenOpt, PlasmaSens, its industrial performance, its investors, its government awards or any projected investment return.
SEC SNAPSHOT
ISSUER: SirenOpt Inc. | CIK: 0002029046 | SEC FILE NO.: 021-598102 | FILM NO.: 261390031 | ACCESSION NO.: 0002029046-26-000004 | FILED / EFFECTIVE: September 18, 2026
ENTITY: Delaware Corporation | INCORPORATED: 2022 | PRINCIPAL ADDRESS: 15555 East 14th Street, Suite 535, San Leandro, CA 94578 | PHONE: 925-330-3249
INDUSTRY: Manufacturing | EXEMPTION: Regulation D Rule 506(b) | POOLED INVESTMENT FUND: No | INVESTMENT COMPANY ACT EXCLUSION: None claimed
SECURITIES: Equity | Security to Be Acquired Upon Exercise of Option, Warrant or Other Right | BUSINESS COMBINATION: No | FIRST SALE: September 10, 2026
TOTAL OFFERING: $32,411,720 | AMOUNT SOLD: $19,428,895 | REMAINING: $12,982,825 | INVESTORS: 17 | MINIMUM INVESTMENT FIELD: $0
SEC CONVERSION DISCLOSURE: $7,411,760 of Total Amount Sold is from conversion of securities.
ARITHMETICAL NON-CONVERSION PORTION: Approximately $12,017,135. This should not automatically be characterized as unrestricted new cash because Form D does not provide a cash-flow reconciliation.
SALES COMMISSIONS: $0 | FINDER FEES: $0 | ITEM 16 RELATED-PERSON PAYMENTS: $0 | REVENUE RANGE: Declined to disclose
RELATED PERSONS: Jared O'Leary — Executive Officer / Director | Ali Mesbah — Director | Tom Chi — Director | Matthew Blain — Director | Philip Harper — Director
FORM D SIGNATORY: Jared O'Leary | TITLE: Chief Executive Officer
ORIGIN: UC Berkeley Chemical Engineering spinout founded in 2022 | FOUNDERS: Jared O'Leary | Ali Mesbah | Joel Paulson.
CORE PLATFORM: PlasmaSens | TECHNOLOGY: cold atmospheric plasma + physics-informed machine learning + predictive analytics for non-destructive, real-time materials characterization.
TARGET MARKETS: battery manufacturing | semiconductors | electronics | aerospace coatings | power-generation components | advanced materials.
2024 PUBLIC SEED ROUND: $6.6M | LEADS: Voyager Ventures and TOMORROW / Visionaries Club.
2025 STRATEGIC CAPITAL CONTEXT: SirenOpt announced investment from Hitachi Ventures and InMotion Ventures to support factory commercialization. The company's public announcement did not make that capital part of the September 2026 Form D.
CALIFORNIA ENERGY COMMISSION: $2.4M BRIDGE grant for battery-electrode inspection and process control.
NSF SBIR PHASE I: $274,770 for a cold-atmospheric-plasma sensor for inline lithium-ion battery electrode metrology.
2026 DEPLOYMENT CONTEXT: SirenOpt states that factory-ready roll-to-roll and piece-to-piece systems have undergone evaluations/deployments internationally and that an inline PlasmaSens Web deployment is planned at California's Electrochemistry Foundry.
IMPORTANT CAPITAL DISTINCTION: The latest $19.428895M Amount Sold includes $7.41176M of converted securities. Prior seed proceeds, strategic investment and government grants must not be added to the Form D figure as if they were all new September 2026 equity cash.
CORE INDEPENDENT FINDING: SirenOpt's latest filing is both a growth financing and a capitalization event. Roughly 38% of the SEC-reported amount sold comes from conversion of earlier securities, while the company simultaneously moves from R&D and evaluation systems toward inline factory deployment. The key diligence questions are how much genuinely new cash entered the company, what dilution resulted from the conversions, how many production systems are operating continuously and whether PlasmaSens generates measurable yield and quality improvements large enough to support repeat industrial purchases.
Form D is an exempt-offering notice and is not an SEC-issued certificate, approval or endorsement.